European Heart Journal - My Cardio Interview: Sunil Rao & Thomas Luscher on INNOVATE PCI

submitted by: OxfordJournals

Sunil Rao in conversation with Thomas Lüscher
INNOVATE PCI: A Phase II Safety and Efficacy Study of PRT060128 (Elinogrel), a Novel Intravenous and Oral P2Y12 Inhibtor in Non-Urgent PCI.

European Heart Journal - My Cardio Interview: Stuart Connolly & Thomas Luscher on AVERROES

submitted by: OxfordJournals

Stuart Connolly in conversation with Thomas Lüscher
AVERROES: Apixaban Versus Acetylsalicyclic Acid (ASA) to Prevent Strokes.

European Heart Journal - My Cardio Interview: Adriaan Voors & Thomas Luscher on HEBE III

submitted by: OxfordJournals

Adriaan Voors in a conversation with Thomas Lüscher
HEBE III: A single dose of erhthropoietin in ST-elevation myocardial infarction.

European Heart Journal - My Cardio Interview: Bertram Pitt & Frank Ruschitzka on PEARL HF

submitted by: OxfordJournals

Bertram Pitt in conversation with Frank Ruschitzka
PEARL HF: Multicentre, randomized, double-blind, placebo-controlled, parallel-group, mulitple-dose study to evaluate the effects of RLY5016 in heart failure patients.

European Heart Journal - My Cardio Interview: Daan Kromhout & John Deanfield on ALPHA OMEGA

submitted by: OxfordJournals

Daan Kromhout in conversation with John Deanfield
ALPHA OMEGA: Effect of low doses of n-3 fatty acids on cardiovascular diseases in post-MI patients.

European Heart Journal - My Cardio Interview: Shinya Goto & Ulf Landmesser on E5555

submitted by: OxfordJournals

Shinya Goto in conversation with Ulf Landmesser
Double-blind placebo controlled phase II studies of E5555 in Japanese patients with Acute Coronary Syndrome (ACS) and Coronary Artery Disease (CAD).

European Heart Journal - My Cardio Interview: Michel Komajda & Frank Ruschitzka on SHIFT

submitted by: OxfordJournals

Michael Komajda in conversation with Frank Ruschitzka
SHIFT: Effects of ivabradine on cardiovascular events in patients with moderate to severe chronic heart failure and left ventricular systolic dysfunction.

European Heart Journal - My Cardio Interview: David Taggart & Ulf Landmesser on ART

submitted by: OxfordJournals

David Taggart in conversation with Ulf Landmesser
ART: A randomised trial to compare survival following bilateral versus single internal mammary (IMA) grafting in coronary revascularisation.

PharmGenEd™ Cardiology I: Warfarin and Statins

submitted by: KuoOffice

This webinar was presented on Tuesday, September 21, 2010 by Dr. Jaekyu Shin and Dr. Larisa Cavallari. Dr. Shin and Dr. Cavallari discuss select pharmacogenomic effects of warfarin and statins.

PharmGenEd™ Cardiology II: Clopidogrel and Beta Blocker

submitted by: KuoOffice

This webinar was presented on Thursday, September 23, 2010 by Dr. Larisa Cavallari and Dr. Jaekyu Shin. Dr. Cavallari and Dr. Shin discuss select pharmacogenomic effects of clopidogrel and beta blockers.